Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin, and endogenous erythropoietin from human urine.

rejection by elevated circulating levels of serum intestinal fatty acid binding protein. Surgery 1993;114:206–10. 12. Ascher N, Stock PG, Baumgarder GL, Payne WD, Najarian JS. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet 1988;167: 474–84. 13. Hughes VF, Trull AK, Joshi O, Alexander GJM. Monitoring eosinophil activation and liver function following liver transplantation. Transplantation 1998; 65:1334–9. 14. Wodzig KW, Kragten JA, Hermens WT, Glatz JF, van Dieijen-Visser MP. Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein: influence of renal function. Eur J Clin Chem Biochem 1997;35:191–8. 15. Rees GW, Trull AK, Doyle S. Evaluation of an enzyme-immunometric assay for serum -glutathione S-transferase. Ann Clin Biochem 1995;32:575–83. 16. Schreiber A, Feldbrugge R, Key G, Glatz JF, Spener F. An immunosensor based on disposable electrodes for rapid estimation of fatty acid-binding protein, an early marker of myocardial infarction. Biosens Bioelectron 1997;12:1131–7. 17. Key G, Schreiber A, Feldbrugge R, McNeil CJ, Jorgenson P, Pelsers MM, et al. Multicenter evaluation of an amperometric immunosensor for plasma fatty acid-binding protein: an early marker for acute myocardial infarction. Clin Biochem 1999;32:229–31. 18. Robers M, van der Hulst FF, Fischer M, Roos W, Salud CE, Eisenwiener HG, et al. Development of a rapid microparticle-enhanced turbidimetric immunoassay for fatty acid-binding protein in plasma, an early marker of acute myocardial infarction. Clin Chem 1998;44:1564–7.